| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 387867-13-2 | 坦度替尼; 4-[6-甲氧基-7-(3-哌啶-1-基丙氧基)喹唑啉-4-基]-N-(4-異丙基氧苯基)哌嗪-1-甲酰胺 | Tandutinib; 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide; (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl) |  | C31H42N6O4 | 詳情 | 供應商 |
| 68214-48-2 | N-[2-[(3-氨基-3-氧代丙基)[2-[二(3-氨基-3-氧代丙基)氨基]乙基]氨基]乙基]十八酰胺單乙酸鹽 | Octadecanamide, N-[2-[(3-amino-3-oxopropyl)[2-[bis(3-amino-3-oxopropyl) amino] ethyl]amino]ethyl]-, |  | C31H62N6O4 | 詳情 | 供應商 |
| 101072-55-3 | L-Leucinamide,L-phenylalanyl-L-prolyl-L-tryptophyl-; 3-6-TryptophyllinL 1.4 (9CI); Tryptophyllin L 1.2 |  | C31H40N6O4 | 詳情 | 供應商 | |
| 917022-13-0 | N-[[反式-4-[[(4-氨基-6-氯-2-嘧啶基)氨基]甲基]環(huán)己基]甲基]-N-[3-[環(huán)己基[(1,1-二甲基乙氧基)羰基]氨基]? | Carbamic acid, N-[[trans-4-[[(4-amino-6-chloro-2-pyrimidinyl)amino]methyl]cyclohexyl]methyl]-N-[3-[; Carbamic acid, N-[[trans-4-[[(4-amino-6-chloro-2-pyrimidinyl)amino]methyl]cyclohexyl]methyl]-N-[3-[cyclohexyl[(1,1-dimethylethoxy)carbonyl]amino]propyl]-, 1,1-dimethylethyl ester; N-[[trans-4-[[(4-Amino-6-chloro-2-pyrimidinyl)amino]methyl]cyclohexyl]methyl]-N-[3-[cyclohexyl[(1,1-dimethylethoxy)carbonyl]amino]propyl]carbamic acid 1,1-dimethylethyl ester |  | C31H53ClN6O4 | 詳情 | 供應商 |
| 204066-82-0 | (S)-A-METHYL-A-[[[(4-NITROPHENYL)AMINO]CARBONYL]AMINO]-N-[[1-(2-PYRIDINYL)CYCLOHEXYL]METHYL]-1H-INDO; (S)-A-METHYL-A-[[[(4-NITROPHENYL)AMINO]CARBONYL]AMINO]-N-[[1-(2-PYRIDINYL)CYCLOHEXYL]METHYL]-1H-INDOLE-3-PROPANAMIDE; PD 168368; (S)-α-Methyl-α-[[[(4-nitrophenyl)amino]carbonyl]amino]-N-[[1-(2-pyridinyl)cyclohexyl]methyl]-1H-indole-3-propanamide |  | C31H34N6O4 | 詳情 | 供應商 |